Earnings8-K
Results of Operations and Financial Condition
Show detailsHide details
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
VCYT
Veracyte, Inc.
A maker of genomic tests that help doctors decide how to treat cancer, Veracyte reads a patient's tumor biology to answer questions like whether a thyroid nodule is benign or a prostate cancer needs aggressive treatment. Its best-known products are the Afirma thyroid test and the Decipher prostate test. Founded in 2006 as Calderome and renamed in 2008, the company's name blends the Latin for "truth" with the Greek suffix for "cell" — a nod to revealing what a patient's cells actually say.
CUSIP: 92337F107HealthcareUS5 holders